Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Multiple Sclerosis: Clinical Features, Pathophysiology, Neuroimaging and Future Therapies Publisher



Borazanci AP1 ; Harris MK1 ; Schwendimann RN1 ; Gonzaleztoledo E1 ; Maghzi AH2 ; Etemadifar M3 ; Alekseeva N1 ; Pinkston J1 ; Kelley RE1 ; Minagar A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Neurology, Louisiana State University Health Sciences Center, Shreveport, LA 71130, 1501 Kings Highway, United States
  2. 2. School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. School of Medicine, Department of Neurology, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Future Neurology Published:2009


Abstract

Multiple sclerosis (MS) is a common immune-mediated progressive neurodegenerative disease of the CNS that typically manifests with periods of disease activity followed by intervals of remission. The etiology of MS remains unknown; however, existing evidence indicates that MS is a 'whole-brain disease' that is driven by a potent immune response against CNS antigen(s), particularly myelin peptide antigens. The immunopathogenesis of MS includes both the cell- and humorally-mediated arms of the immune system. Genetic and environmental factors play important roles in the development of MS. Application of various neuroimaging techniques to the world of MS have expanded our knowledge concerning its pathogenesis and assist us in the more accurate diagnosis of MS versus its imitators. Current treatments target acute attacks and aim to reduce future clinical relapses. A summary of the potential future therapies for MS is presented. © 2009 Future Medicine.
Other Related Docs
12. Serum Level of Interleukin 36 in Patients With Multiple Sclerosis, Journal of Immunoassay and Immunochemistry (2018)
14. A Novel Approach to Discriminate Subgroups in Multiple Sclerosis, Iranian Journal of Allergy, Asthma and Immunology (2016)
33. Color Blindness Among Multiple Sclerosis Patients in Isfahan, Journal of Research in Medical Sciences (2012)
37. Seizure in Iranian Patients With Multiple Sclerosis, Journal of Research in Medical Sciences (2013)
43. Prevalence of Familial Multiple Sclerosis in Isfahan, Iran, Journal of Isfahan Medical School (2011)